James Casey
About James Casey
James Casey serves as the Finance Business Partner to the CIO at The Economist, a position he has held since 2020. He has a diverse background in finance, having worked in various roles across multiple organizations, including ESI Media and NHS.
Current Role at The Economist
James Casey has been serving as the Finance Business Partner to the CIO at The Economist since 2020. In this role, he is responsible for providing financial insights and support to the Chief Information Officer, contributing to strategic financial planning and decision-making processes within the organization.
Previous Positions at The Economist
Before his current role, James Casey held several positions at The Economist. He worked as a Finance Analyst for Content and Events from 2018 to 2020, where he focused on financial analysis related to content production and events. Additionally, he served as a Divisional Finance Analyst from 2017 to 2018, contributing to financial management across various divisions.
Educational Background
James Casey studied at the University of Oxford, where he earned a Master of Chemistry (MChem) degree from 2004 to 2008. His education provided him with a strong analytical foundation, which he has applied throughout his finance career.
Career History in Finance
James Casey has extensive experience in finance, having worked in various roles prior to joining The Economist. He was a Finance Manager at ESI Media from 2015 to 2017 and served as a Senior Management Accountant at Central and North West London NHS Foundation Trust from 2012 to 2013. His career also includes a Graduate Management Trainee position at the NHS Institute for Innovation and Improvement from 2009 to 2012.
Experience in Other Industries
In addition to his roles in finance, James Casey has experience in different sectors. He worked as a Revenue Assurance and Fraud Analyst at Gamma Telecom from 2008 to 2009 and was involved in the London 2012 Olympics as a Venue Entry Team Leader for one month. He also had a brief secondment at GlaxoSmithKline in 2011 as a Business Partner for Hepatitis and Immunology.